|
Market Closed -
Euronext Paris
09:25:00 14/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 156.00 EUR | -0.95% |
|
-3.47% | +31.09% |
| 04/08 | Marengo Therapeutics, Inc. and Ipsen S.A. Nominate First Drug Candidate Under Strategic Tristar Collaboration | CI |
| 03/08 | Jefferies Downgrades Ipsen to Underperform, Boosts PT | MT |
| Market Cap | 1.28TCr 1.48TCr 1.2TCr 1.09TCr 2.06TCr 1,41600Cr 2.09TCr 14TCr 5.51TCr 71TCr 5.56TCr 5.44TCr 2,35600Cr | P/E 2026 * |
13x | P/E 2027 * | 13.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.16TCr 1.34TCr 1.09TCr 989.04Cr 1.86TCr 1,28100Cr 1.89TCr 13TCr 4.98TCr 64TCr 5.03TCr 4.92TCr 2,13200Cr | EV / Sales 2026 * |
2.54x | EV / Sales 2027 * | 2.31x |
| Free-Float |
40.65% | Yield 2026 * |
0.98% | Yield 2027 * | 0.98% |
Last Transcript: Ipsen
| 1 day | -0.95% | ||
| 1 week | -3.47% | ||
| Current month | -6.70% | ||
| 1 month | -2.86% | ||
| 3 months | -6.02% | ||
| 6 months | +0.84% | ||
| Current year | +31.09% |
| 1 week | 153.7 |  | 162.2 |
| 1 month | 153.1 | | 174 |
| Current year | 116 | | 174 |
| 1 year | 109.9 | | 174 |
| 3 years | 87.95 | | 174 |
| 5 years | 77 | | 174 |
| 10 years | 34.2 | | 174 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Loew
CEO | Chief Executive Officer | 59 | 01/07/2020 |
| Chief Executive Officer | 57 | 01/01/2020 | |
Pierrick Lefranc
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Antoine Flochel
BRD | Director/Board Member | 61 | 30/08/2005 |
| Chairman | 68 | 22/11/2010 | |
Carol Xueref
BRD | Director/Board Member | 69 | 01/06/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 31/07/26 | Fiscal year | Chief Executive Officer | -5,000 | 0.0060% | ||
| 25/02/26 | Sell | Chairman | 3,800 | 0.0045% | ||
| 29/05/25 | Fiscal year | Chief Executive Officer | 28,008 | 0.0334% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.95% | -3.47% | +38.67% | +27.35% | 1.48TCr | |
| -2.25% | -0.47% | +68.30% | +115.90% | 1,05200Cr | |
| -0.66% | +0.43% | +47.39% | +50.54% | 63TCr | |
| -0.54% | +1.39% | +20.69% | +63.99% | 44TCr | |
| -1.99% | -3.32% | +38.71% | +35.41% | 35TCr | |
| -1.05% | -2.81% | +23.07% | +35.70% | 29TCr | |
| -2.12% | -3.67% | -1.14% | +5.37% | 24TCr | |
| -0.63% | +1.04% | +40.05% | +56.09% | 22TCr | |
| -1.19% | -3.41% | -9.57% | -52.71% | 20TCr | |
| +0.16% | +3.87% | +16.89% | +73.73% | 17TCr | |
| Average | -1.12% | +0.04% | +28.31% | +41.14% | 36.1TCr | |
| Weighted average by Cap. | -1.36% | +0.30% | +39.09% | +61.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 455.31Cr 527.16Cr 427.85Cr 389.11Cr 731.55Cr 50TCr 743.61Cr 5.01TCr 1.96TCr 25TCr 1.98TCr 1.94TCr 84TCr | 457.09Cr 529.22Cr 429.52Cr 390.63Cr 734.41Cr 51TCr 746.51Cr 5.03TCr 1.97TCr 25TCr 1.99TCr 1.94TCr 84TCr |
| Net income | 100.15Cr 115.96Cr 94Cr 86Cr 160.92Cr 11TCr 163.57Cr 1.1TCr 431.16Cr 5.55TCr 435.37Cr 425.92Cr 18TCr | 96Cr 111.19Cr 90Cr 82Cr 154.3Cr 11TCr 156.84Cr 1.06TCr 413.43Cr 5.32TCr 417.46Cr 408.4Cr 18TCr |
| Net Debt | -121.73Cr -140.94Cr -114.39Cr -104.03Cr -195.59Cr -13TCr -198.81Cr -1.34TCr -524.05Cr -6.75TCr -529.17Cr -517.68Cr -22TCr | -224.1Cr -259.46Cr -210.58Cr -191.51Cr -360.06Cr -25TCr -366Cr -2.47TCr -964.73Cr -12TCr -974.15Cr -953.01Cr -41TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | €156.00 | -0.95% | 79,668 |
| 13/26/13 | €157.50 | +1.29% | 85,759 |
| 12/26/12 | €155.50 | +0.06% | 1,01,777 |
| 11/26/11 | €155.40 | -1.83% | 1,01,074 |
| 10/26/10 | €158.30 | -2.04% | 1,15,723 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IPN Stock
Select your edition
All financial news and data tailored to specific country editions
